Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bradykinin receptor family comprises G-protein coupled receptors (GPCRs) that mediate the biological effects of bradykinin. The two main subtypes are the Bradykinin receptor B1 (B1R) and Bradykinin receptor B2 (B2R). These receptors play key roles in inflammation, pain, and cardiovascular regulation. B2R is constitutively expressed and mediates normal physiological responses, while B1R is inducible upon tissue injury or inflammation and contributes to chronic pain and inflammation.
Activation of G proteins (Gq, Gi) leading to downstream signaling cascades, including phospholipase C activation and increased intracellular calcium, and inhibition of adenylate cyclase.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bradykinin Receptor (BRKR).